BCL2 and B-cell chronic lymphocytic leukemia: The 0.50 μM dose of TP-0903 also had insignificant effect on both Mcl-1 and XIAP expression in CLL B-cells from patient P5 and had no effect on the Bcl-2 level (Figure 4F and Supplementary Figure 3C-3E).